Sort
50,496 grants matching “lung cancer”
Project 1: Biomarkers Of Exposure Versus Effect: Improving The Scientific Basis F
$393,896James A Swenberg · Univ Of North Carolina Chapel Hill · P42 · FY2013 · ES
MOCSLID-CCC
$393,853Donald P Tashkin · University Of California Los Angeles · R01 · FY2011 · HL
Role of Osterix+ Osteolineage Cells in Primary and Metastatic Breast Cancer
$393,846Roberta Faccio · Washington University · R01 · FY2024 · CA
The Role of the Nicotinic Cholinergic Pathway in Retinopathy of Prematurity
$393,837John P Cooke · Methodist Hospital Research Institute · R01 · FY2014 · EY
8P22 ALTERATIONS, IN PROSTATE, BREAST AND ESOPHAGEAL CA
$393,833Thomas Jefferson University · R01 · FY2000 · CA
Using 18F-EF5 PET to measure hypoxia modulation by Nelfinavir in larynx cancer
$393,811Amit Maity · University Of Pennsylvania · R01 · FY2017 · CA
IRE1/XBP1s signaling: a novel essential regulator for bone marrow microenvironmen
$393,773Hongjiao Ouyang · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · CA
Cellular phenotypic heterogeneity and resistance to radiotherapy in pancreatic adenocarcinoma
$393,750Kenneth L Pitter · Ohio State University · DP5 · FY2024 · OD
Cellular phenotypic heterogeneity and resistance to radiotherapy in pancreatic adenocarcinoma
$393,750Kenneth L Pitter · Ohio State University · DP5 · FY2023 · OD
Defining the Complosome in Human Cells, Tissues and Disease States
$393,750John Patterson Atkinson · Washington University · R35 · FY2021 · GM
Healthcare Access Dimensions and Racial Disparities in Lung Cancer
$393,750Ying Liu · Washington University · R01 · FY2021 · MD
Cellular phenotypic heterogeneity and resistance to radiotherapy in pancreatic adenocarcinoma
$393,750Kenneth L Pitter · Ohio State University · DP5 · FY2025 · OD
Cellular phenotypic heterogeneity and resistance to radiotherapy in pancreatic adenocarcinoma
$393,750Kenneth L Pitter · Ohio State University · DP5 · FY2022 · OD
Healthcare Access Dimensions and Racial Disparities in Lung Cancer
$393,750Ying Liu · Washington University · R01 · FY2022 · MD
Cellular phenotypic heterogeneity and resistance to radiotherapy in pancreatic adenocarcinoma
$393,750Kenneth L Pitter · Ohio State University · DP5 · FY2021 · OD
Defining the Complosome in Human Cells, Tissues and Disease States
$393,750John Patterson Atkinson · Washington University · R35 · FY2022 · GM
Defining the Complosome in Human Cells, Tissues and Disease States
$393,748John Patterson Atkinson · Washington University · R35 · FY2023 · GM
Defining the Complosome in Human Cells, Tissues and Disease States
$393,748John Patterson Atkinson · Washington University · R35 · FY2024 · GM
Improving liver lesion biopsy in the CT suite through fusion with PET images
$393,722Kevin Robert Cleary · Kitware, Inc. · R42 · FY2012 · CA
Identifying tumor suppressor targets of SIRT6 in lung cancer
$393,711Marty W Mayo · University Of Virginia · R01 · FY2018 · CA
Role and mechanism of action of p62/Sqstm1 in Ras-induced tumorigenesis in lung
$393,697Jorge Moscat · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2011 · CA
Integrated Development of Novel Molecular Markers
$393,600David Sidransky · Johns Hopkins University · U01 · FY2010 · CA
Scalable decision support and shared decision making for lung cancer screening
$393,596Kensaku Kawamoto · University Of Utah · R18 · FY2021 · HS
Safer lung cancer radiotherapy delivery using novel artificial intelligence methods
$393,581Harini Veeraraghavan · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Role of MED1 in HER2-driven Breast Tumorigenesis
$393,491Xiaoting Zhang · University Of Cincinnati · R01 · FY2018 · CA